NASDAQ: LXEOLexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?
Insider buying vs selling
Have Lexeo Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Longitude Capital Partners Iv LLC | 10% Owner | 2023-11-07 | 454,545 | $11.00 | $5.00MBuy |
| Invest A. Lundbeckfond | 10% Owner | 2023-11-07 | 227,272 | $11.00 | $2.50MBuy |
| Omega Fund Vi LP | 10% Owner | 2023-11-07 | 454,545 | $11.00 | $5.00MBuy |
LXEO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LXEO insiders and whales buy or sell their stock.
LXEO Shareholders
What type of owners hold Lexeo Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eventide Asset Management LLC | 11.26% | 3,002,831 | $37.54M | Institution |
| Longitude Capital Partners Iv LLC | 9.63% | 2,567,100 | $32.09M | Insider |
| D1 Capital Partners LP | 9.40% | 2,506,607 | $31.33M | Institution |
| Janus Henderson Group PLC | 8.74% | 2,330,738 | $29.13M | Institution |
| Omega Fund Management LLC | 8.09% | 2,157,623 | $26.97M | Institution |
| Omega Fund Vi LP | 8.09% | 2,157,623 | $26.97M | Insider |
| Citadel Advisors LLC | 7.82% | 2,084,245 | $26.05M | Institution |
| Invest A. Lundbeckfond | 6.88% | 1,835,959 | $22.95M | Insider |
| Novo Holdings A | 4.90% | 1,307,829 | $16.35M | Institution |
| Blackstone Inc | 2.61% | 696,110 | $8.70M | Institution |
LXEO vs Biotech Stocks
Lexeo Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.